Australia's largest stock trading and investment forum Australia's #1 stock forum

PAR

Click for more information

2.56%

20.0¢ paradigm biopharmaceuticals limited..

Paul Rennie interviewed on Marcus Today Podcast., page-8

First 8 Last

Share
Profile

Follow
goldmad

1,079 Posts.

269

21/02/23

13:54

Post #: 66372614
Share

Originally posted by Mozzarc: ↑

Yes cant quote directly but definitely they are looking at a number of these biomarkers, don't forget this is the latest research and in no way would we have had these available to us way back in the very early days of trial construction a number of years ago now.

Dungiven, as you are most aware, the most exciting thing is that we have not just one world leader in this space working for us, we have two. Felson and Kraus. Dr Kraus in particular will advise the FDA and based on that no doubt we will have future discussions (as slated by PAR). It is in these discussions that suitable endpoints and further study protocols will be engineered and we will have a crystal clear pathway to success, as well on top of what we already have now, my spec views.

I look forward to possibly meeting these two at OARSI. To me at least, it will be like a music fan meeting The Rolling Stones! hahah...except I think we may gather more moss (Future indications and thus future revenue)

We grind closer.

Expand

Hey guys,

Does anyone know if we get accelerated approval, would our clock start on our 3 year exclusivity period or would it only begin after official registration post trial completion?
Could possibly give us a head start on that exclusivity period?

Cheers

PAR Price at posting: $1.46 Sentiment: Hold Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

COB

Cobalt Blue sees A$60M price tag for Kwinana, WA refinery – but $68M value for stage one

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

OJC

SPC to merge with Original Juice Co and Nature One Dairy

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

There are more pages in this discussion • 35 more messages in this thread...

First 8 Last

Add PAR (ASX) to my watchlist

(20min delay)
Last 20.0¢		Change 0.005(2.56%)		Mkt cap ! $70.04M

Open	High	Low	Value	Volume
19.5¢	21.0¢	19.5¢	$80.51K	398.0K

Buyers (Bids)

No.	Vol.	Price($)
5	112938	20.0¢

Sellers (Offers)

Price($)	Vol.	No.
21.0¢	4396	1

View Market Depth

No.	Vol.	Price($)
5	112938	0.200
8	185493	0.195
18	390135	0.190
4	68313	0.185
9	149295	0.180

Price($)	Vol.	No.
0.210	4396	1
0.215	19607	1
0.220	50066	5
0.225	68604	2
0.230	15000	3

Last trade - 16.10pm 02/10/2024 (20 minute delay)

PAR (ASX) Chart